Health Futures

is a government relations, public policy and strategic development firm representing clients in the dynamic new world of predictive and personalized health care. We specialize in navigating the labyrinth of legislators, regulators, health care providers, patient advocates, third-party payers, and journalists who will ultimately determine if innovation succeeds or fails.

Practice Areas Image

Personalized medicine and advanced diagnostics

The promise of research that increases our ability to predict which medical treatments are safe and effective for each patient—and which are not—has ushered in a new era in health care, called personalized medicine. With its acquisition of HealthFutures in 2009, CRD Associates gained a strong foothold in a field where disruptive technologies are the norm. In an effort to keep pace with science, Congress and federal regulators are working to draft policies that foster innovation while simultaneously ensuring that patients have access to high quality, safe medical products. But rapid advances in co-developed drug and diagnostic products, complex laboratory testing, targeted therapeutics and other personalized medicine technologies are outpacing the current regulatory and reimbursement framework and challenging both federal regulators and the industry. Led by a board-certified genetic counselor, the CRD Associates team helps clients anticipate and navigate the regulatory and reimbursement policies for this rapidly growing sector and advises on strategies to further drive the adoption of these products into medical practice.

  • A company that has developed a unique laboratory test sought CRD Associates’ help with raising awareness of the value of risk-stratification tools in the prevention of diabetes. To that end, our firm planned, coordinated and executed a half-day policy symposium on the prevention of type 2 diabetes in partnership with a local academic medical center. The symposium included keynote speakers from well-respected institutions, including the lead investigators implementing the YMCA-United Healthcare-Centers for Disease Control and Prevention (CDC) lifestyle intervention program. We solicited partners for hosting the event, completed all of the planning and day-of logistics and successfully advertised the event that led to more than 100 attendees from industry, the agencies, Congress, academia, and providers and patients.
  • Members of our team recently assisted a medical society in its work with the Centers for Medicare and Medicaid Services (CMS) to develop a National Coverage Determination (NCD) on genetic diagnostic tests for certain cancers. This included preparing an analysis of the draft NCD, assisting experts in the field with drafting and presenting comments before the Medicare Coverage Advisory Committee (MedCAC).